Alnylam Pharmaceuticals
ALNY
#757
Rank
S$42.34 B
Marketcap
S$316.48
Share price
0.33%
Change (1 day)
-45.94%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company